Have you tried to Get Off Elavil only to have the Elavil Withdrawal symptoms force you to reinstate? Harvard Medical School has warned that Tricyclic medications and any anticholingergic medication cause a higher risk of dementia. Elavil, also known as Amtriptyline is often used for sleep, so its critical to promote sleep while you Wean Off Elavil. We use a holistic approach to Elavil Withdrawals, proven over 15 years in 78 countries. Many herbs can interact with Elavil and make Elavil Withdrawals Symptoms increase, that is why we only use natural supplementation that will not interact with Elavil as you Wean Off Elavil slowly. Elavil Withdrawal can occur even after short term use and How to Get Off Elavil can vary, depending on length of time on the drug; other medications; health challenges, etc. If you are looking for Help to Get Off Elavil, please Contact our nonprofit for a free consultation.
SUCCESSFUL CHOICES YOU CAN MAKE RIGHT NOW
"I had been on Elavil for almost 24 yrs when I discovered your Withdrawal Program. I have now been FREE of Elavil and I am feeling fine! I think you are one of Gods angels and I Thank you so very much."
- Linda (Elavil Withdrawal Success Story)
Enter Discount Code ADFree for FREE Ground Shipping on your Withdrawal Program *USA & Canada Only
Our Elavil weaning program is a slow taper that allows you to safely Get Off Elavil under the guidance of Our Team, Your Physician and Pharmacist. The Pre-Taper is for Symptom Relief. You will not wean Elavil until you feel better. This is where our Advanced Nutraceuticals are critical. Point of Return provides healthy, Drug-Free Strategies to help minimize Elavil withdrawal symptoms and support well-being.*
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis. Our In-Home programs are individualized based on your situation. An assessment is done once you start the Elavil Withdrawal Program which allows us to individualize your gameplan based on age; length of time on the medications; health challenges; lifestyle, stress levels; additional medications; and interactions. Don't Wean Elavil alone, work with our Prescription Drug Experts.
Imagine being Free of Elavil Dependency
- Proven Withdrawal Program completed In-Home with Expert Guidance
- Learn how to get off Elavil slowly
- All-Natural Nutraceuticals to help Ease Elavil Withdrawal
- Professional information on interactions
- Free Mentoring on our 24/7 private Discussion Board
- Free Assessment Upon Starting our Program (a $400 value)
ELAVIL WITHDRAWAL SUCCESS STORIES
I owe it all to you, and everyone else at Point of Return. I am forever grateful, and I will never stop telling people about Point of Return. More...
Helyn (Elavil Withdrawal Success Story)
This experience has left me humbled and oh so grateful. Please let Point of Return work for you. They will provide the tools you need to succeed. More...
Liz (Elavil Withdrawal Success Story)
I cannot say enough good things about the entire POR team. I will be forever grateful. Thank you from the bottom of my heart. More...
Robin (Elavil Withdrawal Success Story)
EXPERIENCE and TEAMWORK
using a Natural Approach
Elavil Info and History
Elavil blocks the neurotransmitter acetylcholine in the central and peripheral nervous system, and it's this action that contributes to the numerous side effects, including weight gain, changes in appetite, nausea, constipation, nervousness, muscle stiffness, blurred vision and urinary retention. Elavil should not be abruptly or rapidly discontinued due to the potential of severe withdrawal symptoms. It is recommended to do a slow taper to help minimize symptoms.
Amitriptyline (Elavil) is the most widely used Tricyclic Antidepressant prescribed to treat depression, anxiety, bipolar disorder, attention deficit hyperactivity disorder, insomnia, neuropathic pain and migraines.
Amitriptyline (Elavil) is often used off-label for migraine prevention, yet a study in San Diego showed melatonin was more effective for migraine prevention than Amitriptyline.
Amitriptyline was developed by Merck and initially synthesized in 1960 and approved by the FDA in 1961. Amitriptyline is on the World Health Organization's (WHO) list of most important medications needed in a basic health system.
Elavil also exerts minimal action on Serotonin but significantly on Norepinephrine and these two neurotransmitters also affect the adrenal 'flight-or-fight' system, dream sleep, mood, memory and cardiovascular function.
Elavil side effects may include seizures, urinary retention and a number of heart issues. In the United States and Australia, Amitriptyline is listed as a pregnancy category C drug, meaning it may cause problems during pregnancy. Elavil is known to interact with MAO Inhibitors and SSRIs, risking Serotonin Syndrome.
In June 2011, researchers at the University of East Anglia, Norich, United Kingdom, investigated the anticholinergic burden (ACB) meaning the blocking of acetylcholine, and listed the results. They found that Amtriptyline (Elavil) rated a three, meaning severe due to the reduction in cognitive abilities, adverse side effects and increase in mortality risk.
Elavil Withdrawal Symptoms, Side Effects, Adverse Reactions
ELAVIL WITHDRAWAL SYMPTOMS MAY INCLUDE:
drowsiness, dizziness, dry mouth, blurred vision, constipation, weight gain, or trouble urinating, myocardial infarction, arrhythmia, hypotension, hypertension, palpitation, tachycardia, coma, seizures, hallucinations; delusions, confused states; disorientation, incoordination, tremors, peripheral neuropathy, abnormal involuntary movements, tardive dyskinesia, dysarthria, disturbed concentration, anxiety, insomnia, restlessness, nightmares, drowsiness, dizziness, weakness, fatigue, headache, syndrome of inappropriate ADH secretion, tinnitus, hyperpyrexia, urinary retention, dilation of urinary tract, constipation, blurred vision, increased ocular pressure, skin rash, urticarial, edema of face and tongue, bone marrow depression, nausea, vomiting, anorexia, stomatitis; peculiar taste, diarrhea, black tongue, testicular swelling, breast enlargement – female, increased or decreased libido, impotence, elevation and lowering of blood sugar levels, alopecia, weight gain or loss, urinary frequency, increased perspiration
ELAVIL SIDE EFFECTS MAY INCLUDE:
dizziness, aggression, anxiety, balance issues , blurred vision, brain zaps, concentration impairment, constipation, crying spells, depersonalization, diarrhea, dizziness. electric shock sensations, fatigue, flatulence, flu-like symptoms, hallucinations, hostility, highly emotional, indigestion, irritability, impaired speech, insomnia, jumpy nerves, lack of coordination, lethargy, migraine headaches / increased headaches, nausea, nervousness, over-reacting to situations, paranoia, repetitive thoughts or songs, sensory & sleep disturbances, severe internal restlessness (akathisia), stomach cramps, tremors, tinnitus (ear ringing or buzzing), tingling sensations, troubling thoughts, visual hallucinations / illusions, vivid dreams, speech or visual changes, worsened depression
ELAVIL ADVERSE REACTIONS MAY INCLUDE: per PDR
Severe: visual impairment, liguria, seizures, suicidal ideation, ventricular tachycardia, myocardial infarction, cardiomyopathy, torsade de pointes, arrhythmia exacerbation, heart failure, stroke, AV block, tardive dyskinesia, ocular hypertension, ileus, hepatic failure, vasculitis, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), angioedema, lupus-like symptoms, SIADH, neuroleptic malignant syndrome-like symptoms, serotonin syndrome, agranulocytosis
Moderate: orthostatic hypotension, memory impairment, constipation, blurred vision, palpitations, sinus tachycardia, peripheral vasodilation, urinary retention, amblyopia, hostility, depression, impulse control symptoms, hallucinations, akathisia, delirium, psychosis, mania, edema, hypertension, hypotension, QT prolongation, PR prolongation, dysarthria, ataxia, confusion, peripheral neuropathy, involuntary movements, EEG changes, cycloplegia, hepatitis, stomatitis, jaundice, erythema, eosinophilia, hyperglycemia, hyponatremia, ejaculation dysfunction, hypoglycemia, galactorrhea, impotence (erectile dysfunction), testicular swelling, hyperthermia, leukopenia, thrombocytopenia, neutropenia, withdrawal
Mild: xerostomia, drowsiness, lethargy, weight gain, tremor, dizziness, hyperhidrosis, insomnia, asthenia, dyspepsia, anxiety, paresthesias, fatigue, headache, nausea, diarrhea, rhinitis, anorexia, abdominal pain, pruritus, syncope, polydipsia, agitation, paranoia, restlessness, irritability, weakness, nightmares, weight loss, mydriasis, tongue discoloration, vomiting, dysgeusia, increased urinary frequency, alopecia, rash, urticaria, photosensitivity, breast enlargement, gynecomastia, libido increase, libido decrease, purpura, tinnitus
ELAVIL BOXED WARNINGS: per PDR
The safety and efficacy of amitriptyline (ELAVIL) for the treatment of depression have not been established in children less than 12 years of age. In October 2004, the FDA directed manufacturers of all antidepressants to include a boxed warning detailing the risk of suicide in pediatric patients, including children and adolescents less than 18 years of age, as well as young adults. A causal role has been established for antidepressants in inducing suicidality in pediatric patients. The risk of suicidality for these drugs was identified in a pooled analysis of 24 placebo-controlled trials (n = 4400) lasting up to 16 weeks in pediatric patients with major depressive disorder (MDD), obsessive compulsive disorder (OCD), or other psychiatric disorders. The analysis showed a greater risk of suicidality during the first few months of treatment in those receiving antidepressants (SSRIs and others). The average risk of such events on drug was 4% and 2% for placebo; however, no suicides occurred in these trials. Pooled analysis of short-term clinical trials during early phase treatment with SSRIs and other antidepressants in young adults (18 to 24 years) also showed an increased risk of suicidal thinking and behavior. The clinical need for an antidepressant in children or young adults for any use must be weighed against the risk of increased suicidality; patients who are started on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior, particularly within the first few months of starting therapy or at the time of dose increase or decrease; such observation would generally include at least weekly face-to-face contact with patients during the first 4 weeks of treatment, then every other week visits for the next 4 weeks, then at 12 weeks, and as clinically indicated beyond 12 weeks; additional contact by telephone may be appropriate between visits. It is unknown if the suicidality risk in children and young adults extends to longer-term therapy (i.e., beyond several months). The possibility of a suicide attempt is inherent in patients with depressive symptoms, whether these occur in primary depression or in association with another primary psychiatric disorder. All patients with a history of suicidal ideation or behaviors and those with a prominence of suicidal ideation prior to treatment are considered at an increased risk for suicidal ideation or attempts, and should be closely monitored during treatment with amitriptyline. In patients who exhibit changes in symptoms, worsening of depression or suicidality, a decision should be made to change or discontinue treatment. If discontinuing, medication should be tapered as rapidly as possible, but with recognition that abrupt discontinuation can also cause adverse symptoms. Antidepressants should be prescribed in the smallest quantity consistent with good patient management in order to reduce the risk of overdose.
Elavil References and Information
According to the FDA:
Withdrawal Symptoms After prolonged administration, abrupt cessation of treatment may produce nausea, headache, and malaise. Gradual dosage reduction has been reported to produce, within two weeks, transient symptoms including irritability, restlessness, and dream and sleep disturbance. These symptoms are not indicative of addiction. Rare instances have been reported of mania or hypomania occurring within 2 to 7 days following cessation of chronic therapy with tricyclic antidepressants.
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements/info on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized with Your physician to help you with your drug withdrawal process and with his or her consent and support throughout.
*This program is not meant to cure or prevent any disease or illness.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support throughout the process. More..